Ibex Medical Analytics

Ibex Medical Analytics provides artificial intelligence‐based solutions for pathology and cancer diagnosis, leveraging advanced machine learning technologies to enhance diagnostic accuracy and efficiency.

CCI Score

54.23

-0.03% April 18

Latest Event

Ibex Medical Analytics Achieves HITRUST Certification

Ibex Medical Analytics announced it has earned HITRUST Certification for its information security practices, reinforcing its commitment to robust cybersecurity and protecting sensitive patient data in its AI-powered cancer diagnostics platform.

Take Action

So what can you do? Support Ibex by shopping, spreading the word, or offering your support.

Shop Alternatives SEE ALL: MRFF

Aclarion

NIH
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

LEADER

Ibex Medical Analytics is currently rated as a Leader.

+45 to +100 CCI Score

Companies in this range actively lead the fight against authoritarianism by rejecting oppressive practices and championing democratic values. They implement robust policies, engage in transparent governance, and drive initiatives that set the standard for corporate responsibility.

Latest Events

NOV

14

2023

Ibex Medical Analytics Achieves HITRUST Certification
69.35

Ibex Medical Analytics announced it has earned HITRUST Certification for its information security practices, reinforcing its commitment to robust cybersecurity and protecting sensitive patient data in its AI-powered cancer diagnostics platform.
+80

Technology and Services Impact

March 28

Achieving HITRUST Certification demonstrates Ibex Medical Analytics' adherence to high standards in information security and data protection. This robust cybersecurity measure supports the protection of sensitive patient data and reinforces ethical technology practices, which are aligned with progressive values.

Ibex Medical Analytics Achieves HITRUST Certification Demonstrating the Highest Level of Information Protection Assurance
OCT

30

2023

Ibex Medical Analytics Partners for AI-Driven Cancer Diagnostics
69.06

Ibex Medical Analytics, in collaboration with Roche and AWS, is integrating its AI-powered decision support tools into Roche's Navify digital pathology platform. This partnership aims to streamline pathology workflows, improve diagnostic accuracy, and enhance cancer diagnosis, specifically for breast and prostate cancers.
+80

Technology and Services Impact

March 28

This partnership leverages advanced AI technology in digital pathology to improve diagnostic efficiency and patient care. By integrating AI-driven decision support into Roche's platform, Ibex Medical Analytics demonstrates a commitment to enhancing healthcare outcomes and supporting marginalized communities through improved cancer diagnosis processes. Such technological advancements align with progressive values and resist authoritarian practices by promoting transparency and efficiency in critical public health services.

Roche, Ibex Medical Analytics and AWS partner for better cancer diagnostics
MAR

07

2023

Ibex Secures AI Contract for Cancer Diagnostics in UK
24.27

Ibex Medical Analytics secured multiple contract awards from the PathLAKE consortium to deliver its AI-based Galen™ suite solutions for breast and prostate cancer diagnostics to 25 NHS Trusts, enhancing diagnostic accuracy and efficiency across UK hospitals.
+20

Business Practices and Ethical Responsibility

March 28

The contract award demonstrates ethical business practices, with Ibex leveraging its AI diagnostic solutions to improve healthcare outcomes. The deployment in NHS Trusts signifies a positive contribution to community well-being and aligns with responsible business practices that support marginalized groups through improved access to quality healthcare.

Ibex secures PathLAKE contracts to roll out AI-based cancer diagnostics to UK hospitals
+40

Technology and Services Impact

March 28

Ibex's deployment of the Galen™ suite, an advanced AI diagnostic tool, underscores its significant positive impact on technology and services. This innovative solution not only improves diagnostic accuracy and turnaround times but also supports healthcare workers by alleviating workload pressures, which contributes positively to societal health outcomes.

Ibex secures PathLAKE contracts to roll out AI-based cancer diagnostics to UK hospitals